Kyle Malady, Director: Dexcom DXCM Sell · Filed 25/09/09

Trade details

Type: Insider sale
Amount: $53,933.62
Shares · price: 667 sh · $80.86 a share
Held after: 22,667 sh
Stock: Dexcom DXCM
Person: Kyle MaladyDirector
Trade date: 25/09/05
Filed: 25/09/09
Days to filing: 4 days

Sold 2.9% of holdings

Share of holding sold: 2.9%

Dexcom trades, last 26 weeks

What else happened in Dexcom around then

Filed or reported within 30 days of the trade day · 25/08/06~25/10/05

Kyle Malady's recent trades

Kyle MaladyEVP and Group CEO-VZ Business
Sell10b5-1 planVerizon Communications
Sell10b5-1 plan
Verizon Communications
VZ
$51K
1,100 sh
$51K
Filed 09/30
Traded 09/29
Kyle MaladyEVP and Group CEO-VZ Business
Planned sale10b5-1 planVerizon Communications
Planned sale10b5-1 plan
Verizon Communications
VZ
$51K
1,100 sh
$51K
Filed 09/29
Traded 09/29
Kyle MaladyEVP and Group CEO-VZ Business
Sell10b5-1 planVerizon Communications
Sell10b5-1 plan
Verizon Communications
VZ
$52.4K
1,100 sh
$52.4K
Filed 09/23
Traded 09/22
Kyle MaladyEVP and Group CEO-VZ Business
Planned sale10b5-1 planVerizon Communications
Planned sale10b5-1 plan
Verizon Communications
VZ
$52.4K
1,100 sh
$52.4K
Filed 09/22
Traded 09/22
Kyle MaladyEVP and Group CEO-VZ Business
Planned sale10b5-1 planVerizon Communications
Planned sale10b5-1 plan
Verizon Communications
VZ
$56.3K
1,100 sh
$56.3K
Filed 09/15
Traded 09/15